MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,773.95
+0.66%
NASDAQ 100
$31,076.44
+0.87%
DOW JONES
$51,268.00
+0.18%
NASDAQ Composite
$27,477.31
+1.05%
RUSSELL 2000
$2,833.80
+0.66%
CBOE VIX
$15.52
+1.37%
Sector Heatmap
Technology+0.56%
Financials+0.73%
Healthcare+0.72%
Consumer Cycl+0.35%
Consumer Staples+0.63%
Energy+0.99%
Industrials+0.09%
Materials+1.31%
Real Estate-0.34%
Utilities+0.35%
Comm Services+1.17%
KRRO — Korro Bio, Inc. Common Stock
NasdaqKorro Bio, Inc. Common Stock
$9.97
+0.33(+3.42%)
- O
- 9.70
- H
- 10.10
- L
- 9.41
- V
- 112.18K
⏱️ End-of-day dataAs of Oct 5, 2026
KRRO — Latest News & Headlines
5 StoriesKRRO Oct 2026 10.000 put (KRRO261016P00010000) stock price, news, quote and history - Yahoo Finance Australia
KRRO Oct 2026 10.000 put (KRRO261016P00010000) stock price, news, quote and history Yahoo Finance Australia
HC Wainwright & Co. reiterates Buy rating on Korro Bio, $15 price target - TradingView
HC Wainwright & Co. reiterates Buy rating on Korro Bio, $15 price target TradingView
H.C. Wainwright reiterates Korro Bio stock rating on trial dosing - Investing.com India
H.C. Wainwright reiterates Korro Bio stock rating on trial dosing Investing.com India
Korro Bio doses first patients in urea cycle disorder trial By Investing.com - Investing.com India
Korro Bio doses first patients in urea cycle disorder trial By Investing.com Investing.com India
Korro Bio Begins First Human Trial of KRRO-121 Therapy - TipRanks
Korro Bio Begins First Human Trial of KRRO-121 Therapy TipRanks